TrialAntimicrobial agents and chemotherapy2015

LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus.

Anna C Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.